Repeated Intravitreous Ranibizumab Injections for Diabetic Macular Edema and the Risk of Sustained IOP Elevation or Ocular Hypotensive Treatment

IMPORTANCE: For the management of retinal disease, use of intravitreous injections of anti-vascular endothelial growth factor has increased. Recent reports have suggested that this therapy may cause persistent intraocular pressure (IOP) elevation and potentially increase the risk of glaucoma in pati...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JAMA Ophthalmol
Main Authors: Bressler, Susan B., Almukhtar, Talat, Bhorade, Anjali, Bressler, Neil M., Glassman, Adam R., Huang, Suber S., Jampol, Lee M., Kim, Judy E., Melia, Michele
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4496789/
https://ncbi.nlm.nih.gov/pubmed/25719991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2015.186
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares